Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPAP-BEDDI
PACTR202608506524835Phase 1Not yet recruiting
- Sponsor
- Centre de Recherches Médicales de Lambaréné
- Start
- Sep 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of sulfadoxine, pyrimethamine, artesunate and pyronaridine in malaria, sponsored by Centre de Recherches Médicales de Lambaréné. Primary endpoints: Drug interaction assessment and Bioequivalence assessment. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
sulfadoxinepyrimethamineartesunatepyronaridine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202608506524835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202608506524835.